1. Leiomyosarcoma of the renal vein : analysis of outcome and prognostic factors in the world case series of 67 patientsMarko Novak, Andraž Perhavec, Katherine E. Maturen, Snežana Pavlović Djokić, Simona Jereb, Darja Eržen, 2017, izvirni znanstveni članek Povzetek: Background Leiomyosarcoma is a rare malignant mesenchymal tumour. Some cases of leiomyosarcoma of the renal vein (LRV) have been reported in the literature, but no analysis of data and search for prognostic factors have been done so far. The aim of this review was to describe the LRV, to analyse overall survival (OS), local recurrence free survival (LRFS) and distant metastases free survival (DMFS) in LRV world case series and to identify significant predictors of OS, LRFS and DMFS. Methods Cases from the literature based on PubMed search and a case from our institution were included. Results Sixty-seven patients with a mean age of 56.6 years were identified; 76.1% were women. Mean tumour size was 8.9 cm; in 68.7% located on the left side. Tumour thrombus extended into the inferior vena cava lumen in 13.4%. All patients but one underwent surgery (98.5%). After a median follow up of 24 months, the OS was 79.5%. LRFS was 83.5% after a median follow up of 21.5 months and DMFS was 76.1% after a median follow up of 22 months. Factors predictive of OS in univariate analysis were surgical margins, while factors predictive of LRFS were inferior vena cava luminal extension and grade. No factors predictive of DMFS were identified. In multivariate analysis none of the factors were predictive of OS, LRFS and DMFS. Conclusions Based on the literature review and presented case some conclusions can be made. LRV is usually located in the hilum of the kidney. It should be considered in differential diagnosis of renal and retroperitoneal masses, particularly in women over the age 40, on the left side and in the absence of haematuria. Core needle biopsy should be performed. Patients should be managed by sarcoma multidisciplinary team. LRV should be surgically removed, with negative margins.
Ključne besede: leiomysarcoma, renal vein, surgery, outcomes, prognostic factors
Objavljeno v DiRROS: 24.05.2024; Ogledov: 262; Prenosov: 210
 Celotno besedilo (458,38 KB)
Gradivo ima več datotek! Več... |
2. |
3. Resections of pelvic bone and sacrum, Ljubljana experienceJanez Novak, Marjana Čuček-Pleničar, Darja Eržen, Franc Srakar, Mojca Senčar, Boštjan Baebler, Jožica Červek, Alenka Vodnik-Cerar, Matej Bračko, Živa Pohar-Marinšek, Jožica Anžič, 1997, izvirni znanstveni članek Objavljeno v DiRROS: 16.01.2024; Ogledov: 363; Prenosov: 95
Celotno besedilo (156,79 KB) |
4. Klinični pregled dojkDarja Eržen, 1998, pregledni znanstveni članek Povzetek: Klinični pregled je prva in najpomembnejša metoda v diagnostiki bolezni dojk. Vsebuje štiri faze: anamnezo, inspekcijo in palpacijo, zaključek in zamejitev bolezni. Je osnova za odločitev o nadaljnem postopku (nič, ponovne kontrole, biopsija ali kirurgija). Anamneza je usmerjena na iskanje dejavnikov tveganja za rak dojke. Pri inspekciji in palpaciji smo pozorni na simetričnost dojk, bradavici, kožo dojk, izcedek, vozličavost dojk, tumor, pazdušne in supraklavikularne bezgavke.
Objavljeno v DiRROS: 22.11.2023; Ogledov: 346; Prenosov: 111
Celotno besedilo (133,42 KB) |
5. Smernice zdravljenja raka dojkCvetka Bilban-Jakopin, Jožica Červek, Tanja Čufer, Darja Eržen, Rastko Golouh, Kristijana Hertl, Janez Lamovec, Jurij Lindtner, Elga Majdič, Bojana Pajk, Ana Pogačnik, Miljeva Rener, Barbara Vidergar-Kralj, Maja Primic-Žakelj, Janez Žgajnar, 2004, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Objavljeno v DiRROS: 27.05.2020; Ogledov: 2029; Prenosov: 525
Celotno besedilo (904,07 KB) |
6. |
7. |
8. |
9. Multidisciplinarna obravnava bolnikov s sarkomiDarja Eržen, 2014, objavljeni strokovni prispevek na konferenci Ključne besede: sarkomi, maligni mezenhemski tumorji, citologija, patologija, ortopedija, radioterapija, kirurgija, internistična onkologija
Objavljeno v DiRROS: 17.09.2019; Ogledov: 2540; Prenosov: 735
Celotno besedilo (128,36 KB) |
10. |
